Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate

References

• Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth. Analg. 114(2), 261–274 (2012).
   PubMed Web of Science ®Google Scholar
• Ives C, Inaba K, Branco BC et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J. Am. Coll. Surg. 215(4), 496–502 (2012).
   PubMed Web of Science ®Google Scholar
• Maegele M, Paffrath T, Bouillon B. Acute traumatic coagulopathy in severe injury: incidence, risk stratification, and treatment options. Dtsch. Arztebl. Int. 108(49), 827–835 (2011).
   PubMed Web of Science ®Google Scholar
• Franchini M, Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus. 10(1), 23–27 (2012).
   PubMed Web of Science ®Google Scholar
• Schöchl H, Schlimp CJ, Voelckel W. Potential value of pharmacological protocols in trauma. Curr. Opin. Anaesthesiol. 26(2), 221–229 (2013).
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ. J. 74(4), 597–607 (2010).
   PubMed Web of Science ®Google Scholar
• Sørensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C. Fibrinogen as a hemostatic agent. Semin. Thromb. Hemost. 38(3), 268–273 (2012).
   PubMed Web of Science ®Google Scholar
• Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 48(10), 2152–2158 (2008).
   PubMed Web of Science ®Google Scholar
• Solomon C, Pichlmaier U, Schoechl H et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br. J. Anaesth. 104(5), 555–562 (2010).
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br. J. Anaesth. 101(6), 769–773 (2008).
   PubMed Web of Science ®Google Scholar
• Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br. J. Anaesth. 105(2), 116–121 (2010).
   PubMed Web of Science ®Google Scholar
• Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr. Opin. Anaesthesiol. 22(2), 267–274 (2009).
   PubMed Web of Science ®Google Scholar
• Rossaint R, Bouillon B, Cerny V et al.; Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: an updated European guideline. Crit. Care 14(2), R52 (2010).
   PubMed Web of Science ®Google Scholar
• Thomas D, Wee M, Clyburn P et al. Association of Anaesthetists of Great Britain and Ireland. Guidelines: blood transfusion and the anesthetist: management of massive haemorrhage. Anaesthesia 65, 1153–1161 (2010).
   PubMedGoogle Scholar
• Rahe-Meyer N, Solomon C, Hanke A et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 118(1), 40–50 (2013).
   PubMed Web of Science ®Google Scholar
• Clauss A. [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 17(4), 237–246 (1957).
   PubMedGoogle Scholar
• Solomon C, Cadamuro J, Ziegler B et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 51(8), 1695–1706 (2011).
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sørensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 50(12), 2571–2576 (2010).
   PubMed Web of Science ®Google Scholar
• Davenport R, Manson J, De’Ath H et al. Functional definition and characterization of acute traumatic coagulopathy. Crit. Care Med. 39(12), 2652–2658 (2011).
   PubMed Web of Science ®Google Scholar
• Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand. J. Trauma. Resusc. Emerg. Med. 17, 45 (2009).
   PubMed Web of Science ®Google Scholar
• Sawyer MM, Myers G, Humphrey J, Chandler M. Trauma and thrombelastography: how changes in the understanding of coagulopathy, testing, and hospital systems have changed one group’s practice. Semin. Cardiothorac. Vasc. Anesth. 16(3), 142–152 (2012).
   PubMedGoogle Scholar
• Schöchl H, Cadamuro J, Seidl S et al. Hyperfibrinolysis is common in out-of-hospital cardiac arrest: results from a prospective observational thromboelastometry study. Resuscitation 84(4), 454–459 (2013).
   PubMed Web of Science ®Google Scholar
• Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract. Res. Clin. Anaesthesiol. 24(1), 27–40 (2010).
   PubMedGoogle Scholar
• Fluger I, Maderova K, Simek M, Hajek R, Zapletalova J, Lonsky V. Comparison of functional fibrinogen assessment using thromboelastography with the standard von Clauss method. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 156(3), 260–261 (2012).
   PubMed Web of Science ®Google Scholar
• Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart. Lung Circ. 18(4), 277–288 (2009).
   PubMed Web of Science ®Google Scholar
• Weber CF, Zacharowski K. Perioperative point of care coagulation testing. Dtsch. Arztebl. Int. 109(20), 369–375 (2012).
   PubMed Web of Science ®Google Scholar
• Tziomalos K, Vakalopoulou S, Perifanis V, Garipidou V. Treatment of congenital fibrinogen deficiency: overview and recent findings. Vasc. Health Risk Manag. 5, 843–848 (2009).
   PubMedGoogle Scholar
• Rourke C, Curry N, Khan S et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J. Thromb. Haemost. 10(7), 1342–1351 (2012).
   PubMed Web of Science ®Google Scholar
• Karlsson M, Ternström L, Hyllner M et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb. Haemost. 102(1), 137–144 (2009).
   PubMed Web of Science ®Google Scholar
• Rahe-Meyer N, Pichlmaier M, Haverich A et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br. J. Anaesth. 102(6), 785–792 (2009).
   PubMed Web of Science ®Google Scholar
• Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 113(5), 1205–1219 (2010).
   PubMed Web of Science ®Google Scholar
• Koscielny J, von Tempelhoff GF, Ziemer S et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin. Appl. Thromb. Hemost. 10(2), 155–166 (2004).
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P. Rare bleeding disorders. Haemophilia 18(Suppl. 4), 148–153 (2012).
   PubMedGoogle Scholar
• Peyvandi F, Di Michele D, Bolton-Maggs PH, Lee CA, Tripodi A, Srivastava A; Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J. Thromb. Haemost. 10(9), 1938–1943 (2012).
   PubMed Web of Science ®Google Scholar
• Aljassim O, Karlsson M, Wiklund L, Jeppsson A, Olsson P, Berglin E. Inflammatory response and platelet activation after off-pump coronary artery bypass surgery. Scand. Cardiovasc. J. 40(1), 43–48 (2006).
   PubMed Web of Science ®Google Scholar
• Danés AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang. 94(3), 221–226 (2008).
   PubMed Web of Science ®Google Scholar
• Benjamin RJ, McLaughlin LS. Plasma components: properties, differences, and uses. Transfusion 52(Suppl. 1), S9–S19 (2012).
   Google Scholar
• Seghatchian J, Struff WG, Reichenberg S. Main properties of the THERAFLEX MB-plasma system for pathogen reduction. Transfus. Med. Hemother. 38(1), 55–64 (2011).
   PubMed Web of Science ®Google Scholar
• Pool JG, Gershgold EJ, Pappenhagen AR. High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature 203, 312 (1964).
   PubMed Web of Science ®Google Scholar
• Sparrow RL, Greening DW, Simpson RJ. A protocol for the preparation of cryoprecipitate and cryodepleted plasma. Methods Mol. Biol. 728, 259–265 (2011).
   PubMedGoogle Scholar
• Standards for Blood Banks and Transfusion Services (27th Edition). American Association of Blood Banks, MD, USA (2011).
   Google Scholar
• Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowledge. Transfus. Med. Rev. 23(3), 177–188 (2009).
   PubMed Web of Science ®Google Scholar
• Serrano K, Scammell K, Weiss S et al. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Transfusion 50(2), 344–353 (2010).
   PubMed Web of Science ®Google Scholar
• Nugent DJ. Prophylaxis in rare coagulation disorders – factor XIII deficiency. Thromb. Res. 118(Suppl. 1), S23–S28 (2006).
   PubMed Web of Science ®Google Scholar
• Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br. J. Anaesth. 109(2), 135–137 (2012).
   PubMed Web of Science ®Google Scholar
• Ahmed S, Harrity C, Johnson S et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage – an observational study. Transfus. Med. 22(5), 344–349 (2012).
   PubMed Web of Science ®Google Scholar
• Schöchl H, Nienaber U, Hofer G et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit. Care 14(2), R55 (2010).
   PubMed Web of Science ®Google Scholar
• Rahe-Meyer N, Solomon C, Winterhalter M et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J. Thorac. Cardiovasc. Surg. 138(3), 694–702 (2009).
   PubMed Web of Science ®Google Scholar
• Thorarinsdottir HR, Sigurbjornsson FT, Hreinsson K, Onundarson PT, Gudbjartsson T, Sigurdsson GH. Effects of fibrinogen concentrate administration during severe hemorrhage. Acta Anaesthesiol. Scand. 54(9), 1077–1082 (2010).
   PubMed Web of Science ®Google Scholar
• Searle E, Pavord S, Alfirevic Z. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage. Best Pract. Res. Clin. Obstet. Gynaecol. 22(6), 1075–1088 (2008).
   PubMed Web of Science ®Google Scholar
• Lancé MD, Ninivaggi M, Schols SE et al. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial. Vox Sang. 103(1), 25–34 (2012).
   PubMed Web of Science ®Google Scholar
• Solomon C, Schöchl H, Hanke A et al. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. Scand. J. Clin. Lab. Invest. 72(2), 121–128 (2012).
   PubMed Web of Science ®Google Scholar
• Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus. Med. 18(3), 151–157 (2008).
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Jensen TM, Kristensen BS et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J. Thromb. Haemost. 7(5), 795–802 (2009).
   PubMed Web of Science ®Google Scholar
• Lang T, Johanning K, Metzler H et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth. Analg. 108(3), 751–758 (2009).
   PubMed Web of Science ®Google Scholar
• Velik-Salchner C, Haas T, Innerhofer P et al. The effect of fibrinogen concentrate on thrombocytopenia. J. Thromb. Haemost. 5(5), 1019–1025 (2007).
   PubMed Web of Science ®Google Scholar
• Cui Y, Hei F, Long C et al. Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. Artif. Organs 34(11), 955–960 (2010).
   PubMed Web of Science ®Google Scholar
• WHO. Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations. WHO, Geneva, Switzerland (2009).
   Google Scholar
• Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica 92(6), 846–849 (2007).
   PubMed Web of Science ®Google Scholar
• Groner A. Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica 93(2), e24–e26; author reply e27 (2008).
   PubMed Web of Science ®Google Scholar
• Ludlam CA, Powderly WG, Bozzette S et al. Clinical perspectives of emerging pathogens in bleeding disorders. Lancet 367(9506), 252–261 (2006).
   PubMed Web of Science ®Google Scholar
• Hornsey VS, Young DA, Docherty A, Hughes W, Prowse CV. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration. Transfus. Med. 14(5), 369–374 (2004).
   PubMed Web of Science ®Google Scholar
• Fast LD, Nevola M, Tavares J, Reddy HL, Goodrich RP, Marschner S. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion 53(2), 373–381 (2013).
   PubMed Web of Science ®Google Scholar
• Sørensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br. J. Haematol. 149(6), 834–843 (2010).
   PubMed Web of Science ®Google Scholar
• Theodoulou A, Berryman J, Nathwani A, Scully M. Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. Transfus. Apher. Sci. 46(2), 159–162 (2012).
   PubMed Web of Science ®Google Scholar
• Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul. Fibrinolysis 20(7), 535–540 (2009).
   PubMed Web of Science ®Google Scholar
• Circular of Information for the Use of Human Blood and Blood Components. American Association of Blood Banks, MD, USA (2009).
   Google Scholar
• RiaSTAP™ (fibrinogen concentrate [human]), package insert. CSL Behring, IL, USA.
   Google Scholar
• Shaz B, Hilllyer C. Cryoprecipitate. In: Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. Hillyer C, Shaz B, Zimring J, Abshire T (Eds). Elsevier, PA, USA 175–178 (2009).
   Google Scholar
• Shaz BH, Dente CJ, Nicholas J et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 50(2), 493–500 (2010).
   PubMed Web of Science ®Google Scholar
• Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 50(4), 753–765 (2010).
   PubMed Web of Science ®Google Scholar
• Toner RW, Pizzi L, Leas B, Ballas SK, Quigley A, Goldfarb NI. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl. Health Econ. Health Policy 9(1), 29–37 (2011).
   PubMedGoogle Scholar
• Matijevic N, Wang YW, Kostousov V, Wade CE, Vijayan KV, Holcomb JB. Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb. Res. 128(1), 35–41 (2011).
   PubMed Web of Science ®Google Scholar
• Habib S, Gader A, Kurdi M, Suriya M, Aseri Z. Tissue plasmonogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina. JPMA 62, 681–685 (2012).
   Google Scholar
• Mühl D. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism]. Orv. Hetil. 149(20), 935–948 (2008).
   PubMedGoogle Scholar
• Kochetov AG, Karpova OV, Arkhipkin AA et al. [The prognostic significance of fibrinogen concentration in patients with ischemic stroke without thrombolytic treatment]. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 110(12 Pt 2), 46–51 (2010).
   PubMedGoogle Scholar
• Droubatchevskaia N, Wong M, Chipperfield K, Wadsworth L, Ferguson D. Guidelines for cryoprecipiate transfusion. BC Med. J. 49, 441–445 (2007).
   Google Scholar